AR005136A1 - Compuestos antibioticos oligosacaridos hidrosolubles, una composicion farmaceutica que los contienen y el uso de los mismos para la preparacion de un medicamento - Google Patents
Compuestos antibioticos oligosacaridos hidrosolubles, una composicion farmaceutica que los contienen y el uso de los mismos para la preparacion de un medicamentoInfo
- Publication number
- AR005136A1 AR005136A1 ARP960105762A ARP960105762A AR005136A1 AR 005136 A1 AR005136 A1 AR 005136A1 AR P960105762 A ARP960105762 A AR P960105762A AR P960105762 A ARP960105762 A AR P960105762A AR 005136 A1 AR005136 A1 AR 005136A1
- Authority
- AR
- Argentina
- Prior art keywords
- preparation
- soluble
- oligosaccharid
- hydro
- contain
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 230000003115 biocidal effect Effects 0.000 title abstract 2
- 229920001542 oligosaccharide Polymers 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 150000002482 oligosaccharides Chemical class 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Abstract
Se describen los compuestos antibioticos oligosacaridos hidrosolubles de la formula (I), en la cual R1, R2, R3, R4, R5, R6, R7 y R8 son hidrogeno y losrestantes son grupos que se pueden convertir in vivo en hidrogeno; y composiciones farmaceuticasque los contienen. Ademas se refiere al uso dedichos compuestos de formula (I) para la preparacion de un medicamento util para el tratamiento y/o prevencion de infecciones bacterianas en un mamifero.Estos compuestos son agentes antibacte rianos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/577,656 US5652226A (en) | 1995-12-22 | 1995-12-22 | Water soluble antibiotics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR005136A1 true AR005136A1 (es) | 1999-04-14 |
Family
ID=24309623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP960105762A AR005136A1 (es) | 1995-12-22 | 1996-12-18 | Compuestos antibioticos oligosacaridos hidrosolubles, una composicion farmaceutica que los contienen y el uso de los mismos para la preparacion de un medicamento |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US5652226A (es) |
| EP (1) | EP0876386A1 (es) |
| JP (1) | JPH11501670A (es) |
| KR (1) | KR19990076656A (es) |
| CN (1) | CN1209134A (es) |
| AR (1) | AR005136A1 (es) |
| AU (1) | AU720096B2 (es) |
| BR (1) | BR9612223A (es) |
| CA (1) | CA2240767A1 (es) |
| CZ (1) | CZ194998A3 (es) |
| IL (1) | IL125063A0 (es) |
| MX (1) | MX9804955A (es) |
| NO (1) | NO982879L (es) |
| NZ (1) | NZ325591A (es) |
| PL (1) | PL327184A1 (es) |
| SK (1) | SK86598A3 (es) |
| WO (1) | WO1997023495A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5763600A (en) * | 1997-04-18 | 1998-06-09 | Schering Corporation | Oligosaccharide antibiotics and process for preparation thereof |
| CN117024611B (zh) * | 2023-03-01 | 2024-05-17 | 中国科学院南海海洋研究所 | 寡糖类抗生素everninomicin高产菌株的构建及活性的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4597968A (en) * | 1982-08-06 | 1986-07-01 | Schering Corporation | Antibiotic 13-384 complex from Micromonospora carbonacea var africana |
| US4622314A (en) * | 1985-10-15 | 1986-11-11 | Schering Corporation | Substituted oligosaccharide antibiotics |
| US4767748A (en) * | 1985-10-15 | 1988-07-30 | Schering Corporation | Substituted oligosaccharide antibodies |
| US5627165A (en) * | 1990-06-13 | 1997-05-06 | Drug Innovation & Design, Inc. | Phosphorous prodrugs and therapeutic delivery systems using same |
| KR100249584B1 (ko) * | 1991-10-16 | 2000-04-01 | 둘락 노먼 씨. | 친지질성 올리고삭카라이드 항생제 염 조성물 |
-
1995
- 1995-12-22 US US08/577,656 patent/US5652226A/en not_active Expired - Fee Related
-
1996
- 1996-12-18 CZ CZ981949A patent/CZ194998A3/cs unknown
- 1996-12-18 AU AU14131/97A patent/AU720096B2/en not_active Ceased
- 1996-12-18 AR ARP960105762A patent/AR005136A1/es unknown
- 1996-12-18 WO PCT/US1996/019599 patent/WO1997023495A1/en not_active Ceased
- 1996-12-18 PL PL96327184A patent/PL327184A1/xx unknown
- 1996-12-18 IL IL12506396A patent/IL125063A0/xx unknown
- 1996-12-18 CN CN96199984A patent/CN1209134A/zh active Pending
- 1996-12-18 JP JP9523683A patent/JPH11501670A/ja active Pending
- 1996-12-18 CA CA002240767A patent/CA2240767A1/en not_active Abandoned
- 1996-12-18 BR BR9612223A patent/BR9612223A/pt unknown
- 1996-12-18 EP EP96944283A patent/EP0876386A1/en not_active Withdrawn
- 1996-12-18 KR KR1019980704767A patent/KR19990076656A/ko not_active Ceased
- 1996-12-18 NZ NZ325591A patent/NZ325591A/en unknown
- 1996-12-18 SK SK865-98A patent/SK86598A3/sk unknown
- 1996-12-20 US US08/770,469 patent/US5795874A/en not_active Expired - Fee Related
-
1998
- 1998-06-19 MX MX9804955A patent/MX9804955A/es unknown
- 1998-06-19 NO NO982879A patent/NO982879L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU1413197A (en) | 1997-07-17 |
| CN1209134A (zh) | 1999-02-24 |
| IL125063A0 (en) | 1999-01-26 |
| EP0876386A1 (en) | 1998-11-11 |
| NO982879D0 (no) | 1998-06-19 |
| US5652226A (en) | 1997-07-29 |
| MX9804955A (es) | 1998-09-30 |
| WO1997023495A1 (en) | 1997-07-03 |
| NO982879L (no) | 1998-08-20 |
| CZ194998A3 (cs) | 1998-10-14 |
| US5795874A (en) | 1998-08-18 |
| SK86598A3 (en) | 2000-01-18 |
| JPH11501670A (ja) | 1999-02-09 |
| PL327184A1 (en) | 1998-11-23 |
| NZ325591A (en) | 1999-10-28 |
| AU720096B2 (en) | 2000-05-25 |
| BR9612223A (pt) | 1999-07-13 |
| KR19990076656A (ko) | 1999-10-15 |
| CA2240767A1 (en) | 1997-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ504986A (en) | Erythromycin and azalide derivatives and pharmaceutical compositions thereof, useful as antibacterial agents and antoprotozoa agents | |
| BG103945A (en) | Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a | |
| AP2001002222A0 (en) | Ketolide antibiotics. | |
| GEP20053429B (en) | 3-Aminoquinazolin-2,4-Dione, Pharmaceutical Composition Containing Them and Use Thereof as Antibacterial Agents | |
| TR199901127T2 (xx) | Antibakteriyel etkili 6-O-ikameli ketolitler. | |
| DE69908819D1 (de) | Glycopeptid-derivate und pharmazeutische zusammensetzungen, die sie enthalten | |
| IL108520A0 (en) | Imidazopyridine derivatives, processes for the preparation thereof, and pharmaceutical compositions containing them | |
| ATE113604T1 (de) | Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen. | |
| DE69713151D1 (de) | Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung | |
| TR199902995T2 (xx) | 9-Oksim eritromisin t�revleri | |
| IL113160A (en) | Lipopeptide a1437 derivatives a process for their preparation and pharmaceutical compositions containing them | |
| PA8485601A1 (es) | Azalidas de 13 miembros y su uso como agentes antibioticos. | |
| AR004510A1 (es) | Composiciones que comprenden amoxicilina y clavulanato, procedimientos para su preparacion y el uso de las composiciones para la fabricacion de unmedicamento | |
| PA8465901A1 (es) | Nuevos derivados de la eritromicina | |
| AP9801377A0 (en) | Tricyclic erythromycin derivatives. | |
| ES2116612T3 (es) | Nuevas bis-naftalimidas para el tratamiento del cancer. | |
| GEP20032970B (en) | Pharmaceutical Compositions of Tizoxanide and Nitazoxanide | |
| AR005136A1 (es) | Compuestos antibioticos oligosacaridos hidrosolubles, una composicion farmaceutica que los contienen y el uso de los mismos para la preparacion de un medicamento | |
| AR021463A1 (es) | Antibiotico de piridona con perfil de seguridad mejorado | |
| TNSN00103A1 (fr) | Formes cristallines nouvelles d'un antibiotique macrolide, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MX9300205A (es) | Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene. | |
| AP9801235A0 (en) | Erythromycin derivatives. | |
| TR199801835A2 (xx) | Antimikrobiyal kompozisyonlar. | |
| GT199900153A (es) | Antibiòticos de carbamato y carbamato cetolida.- | |
| GT199600061A (es) | Polimorfos de profarmaco de 6-n- (l-ala-l-ala)-trovafloxacina. |